Regulation of Presynaptic Ca2+, Synaptic Plasticity and Contextual Fear Conditioning by a N-Terminal β-Amyloid Fragment

Journal of Neuroscience

Volumn 34, Issue 43, 2014, Pages 14210-14218

  Lawrence, James L M ^a   Tong, Mei ^a,b   Alfulaij, Naghum ^a   Sherrin, Tessi ^a   Contarino, Mark ^b   White, Michael M ^b   Bellinger, Frederick P ^a   Todorovic, Cedomir ^a   Nichols, Robert A ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Ca regulation; Fear memory; Neuromodulation; Synaptic plasticity; amyloid

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; BETA SECRETASE; BUNGAROTOXIN RECEPTOR; CALCIUM ION; CARBOXYPEPTIDASE; COMPLEMENTARY DNA; NICOTINIC RECEPTOR BLOCKING AGENT; CALCIUM;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; FEAR; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; LONG TERM POTENTIATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMORY CONSOLIDATION; MOUSE; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROBLASTOMA CELL LINE; NEUROMODULATION; NONHUMAN; POST TETANIC POTENTIATION; PRESYNAPTIC NERVE; PRESYNAPTIC POTENTIAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SPECTROFLUOROMETRY; SYNAPTOSOME; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CONDITIONING; DRUG EFFECTS; MOLECULAR GENETICS; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM; CELL LINE, TUMOR; CONDITIONING (PSYCHOLOGY); FEAR; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; NEURONAL PLASTICITY; ORGAN CULTURE TECHNIQUES; PRESYNAPTIC TERMINALS;

EID: 84908081507     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0326-14.2014     Document Type: Article

References (45)

1. Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I (2009) Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12:1567–1576. CrossRef Medline
2. Bell KA, O’Riordan KJ, Sweatt JD, Dineley KT (2004) MAPKrecruitment by β-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time. J Neurochem 91:349-361. CrossRef Medline
3. Bellinger FP, Wilce PA, Bedi KS, Wilson P (2002) Long-lasting synaptic modification in the rat hippocampus resulting from NMDA receptor blockade during development. Synapse 43:95–101. CrossRef Medline
4. Buée L, Ding W, Delacourte A, Fillit H (1993) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer’s amyloid A4 peptide. Brain Res 601:154-163. CrossRef Medline
5. Chin JH, Ma L, MacTavish D, Jhamandas JH (2007) Amyloid β protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors. J Neurosci 27:9262–9269. CrossRef Medline
6. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron 48:913–922. CrossRef Medline
7. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron 58:42–51. CrossRef Medline
8. Dellisanti CD, Yao Y, Stroud JC, Wang ZZ, Chen L (2007) Crystal structure of the extracellular domain of nAChR β1 bound to β-bungarotoxin at 1.94 Å resolution. Nat Neurosci 10:953–962. CrossRef Medline
9. Dougherty JJ, Wu J, Nichols RA (2003) Aβ-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23: 6740–6747. Medline
10. Dunkley PR, Jarvie PE, Health JW, Kidd GJ, Rostas JAP (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 327:115–129. CrossRef Medline
11. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, Mc- Clure D, Ward PJ (1990) Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248:1122–1124. CrossRef Medline
12. Golde TE, Eckman CB, Younkin SG (2000) Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Biochim Biophys Acta 1502:172–187. CrossRef Medline
13. Harmeier A, Wozny C, Rost BR, Munter LM, Hua H, Georgiev O, Beyermann M, Hildebrand PW, Weise C, Schaffner W, Schmitz D, Multhaup G (2009) Role of amyloid-β glycine 33 in oligomerization, toxicity, and neuronal plasticity. J Neurosci 29:7582–7590. CrossRef Medline
14. Khan GM, Tong M, Jhun M, Arora K, Nichols RA (2010) β-amyloid activates presynapticβ7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts. Eur J Neurosci 31: 788–796. CrossRef Medline
15. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A 87:1561–1565. CrossRef Medline
16. Liu QS, Kawai H, Berg DK (2001) β-amyloid peptide blocks the response of β7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 98:4734–4739. CrossRef Medline
17. Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, Tampellini, Klann E, Blitzer RD, Gouras GK (2010) Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer’s disease. PLoS One 5:e12845. CrossRef Medline
18. Marcinkiewicz M, Seidah NG (2000) Coordinated expression of β-amyloid precursor protein and the putative β-secretase BACE and β-secretase ADAM10 in mouse and human brain. J Neurochem 75:2133–2143. CrossRef Medline
19. Mehta TK, Dougherty JJ, Wu J, Choi CH, Khan GM, Nichols RA (2009) Defining pre-synaptic nicotinic receptors regulated by beta amyloid in mouse cortex and hippocampus with receptor null mutants. J Neurochem 109:1452–1458. CrossRef Medline
20. Morimoto A, Irie K, Murakami K, Masuda Y, Ohigashi H, Nagao M, Fukuda H, Shimizu T, Shirasawa T (2004) Analysis of the secondary structure of β-amyloid (Aβ42) fibrils by systematic proline replacement. J Biol Chem 279:52781–52788. CrossRef Medline
21. Nelson P, Christian C, Nirenberg M (1976) Synapse formation between clonal neuroblastomaXglioma hybrid cells and striated muscle cells. Proc Natl Acad Sci U S A 73:123–127. CrossRef Medline
22. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41:27–33. CrossRef Medline
23. Patel AN, Jhamandas JH (2012) Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain. Expert Rev Mol Med 14:e2. CrossRef Medline
24. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, Ed 2. San Diego: Academic.
25. Pettit DL, Shao Z, Yakel JL (2001) Aβ-amyloid1–42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21:RC120. Medline
26. Pirttimaki TM, Codadu NK, Awni A, Pratik P, Nagel DA, Hill EJ, Dineley KT, Parri HR (2013) β7 nicotinic receptor-mediated astrocytic gliotransmitter release: Aβ effects in a preclinical Alzheimer’s mouse model. PLoS One 8:e81828. CrossRef Medline
27. Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmalm G, Zetterberg H, Blennow K, Westman-Brinkmalm A (2007) Characterization of amyloid β peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6:4433–4439. CrossRef Medline
28. Portelius E, Andreasson U, Ringman JM, Buerger K, Daborg J, Buchhave P, Hansson O, Harmsen A, Gustavsson MK, Hanse E, Galasko D, Hampel H, Blennow K, Zetterberg H (2010a) Distinct cerebrospinal fluid amyloid β peptide signatures I sporadic and PSEN1 A431E-associated familial Alzheimer’s disease. Mol Neurodegen 5:2. CrossRef
29. Portelius E, Dean RA, Gustavsson MK, Andreasson U, Zetterberg H, Siemers E, Blennow K (2010b) A novel Aβ isoform pattern in CSF reflects β-secretase inhibition in Alzheimer’s disease. Alzheimers Res Ther 2:7. CrossRef Medline
30. Portelius E, Price E, Brinkmalm G, Stiteler M, Olsson M, Persson R, Westman-Brinkmalm A, Zetterberg H, Simon AJ, Blennow K (2011) A novel pathway for amyloid precursor protein processing. Neurobiol Aging 32:1090-1098. CrossRef Medline
31. Puzzo D, Privitera L, Leznik E, Fà M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28:14537–14545. CrossRef Medline
32. Puzzo D, Privitera L, Fa’ M, Staniszewski A, Hashimoto G, Aziz F, Sakurai M, Ribe EM, Troy CM, Mercken M, Jung SS, Palmeri A, Arancio O (2011) Endogenous amyloid-β is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69:819–830. CrossRef Medline
33. Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R (2007) Synaptic memory mechanisms: Alzheimer’s disease amyloid β-peptide-induced dysfunction. Biochem Soc Trans 35:1219-1223. CrossRef Medline
34. Schubert W, Prior R, Weidemann A, Dircksen H, Multhaup G, Masters CL, Beyreuther K (1991) Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res 563:184-194. CrossRef Medline
35. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:742–766. Medline
36. Selkoe DJ, Schenk D (2003) Alzheimer’s disease: molecular understanding predicts molecular-based therapeutics. Annu Rev Pharmacol Toxicol 43: 545–584. CrossRef Medline
37. Sherrin T, Blank T, Hippel C, Rayner M, Davis RJ, Todorovic C (2010) Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning. J Neurosci 30:13348-13361. CrossRef Medline
38. Shin BK, Saxena S (2011) Substantial contribution of the two imidazole rings of His13-His14 dyad to Cu(II) binding in amyloid-β(1–16) at physiologicalpH and its significance. J Phys Chem A 115:9590–9602. CrossRef Medline
39. Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM (2000) Protein kinase C-dependentβ-secretase competes withβ-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network. J Biol Chem 275:2568-2575. CrossRef Medline
40. Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing and function. J Biol Chem 283:29615–29619. CrossRef Medline
41. Tippmann F, Hundt J, Schneider A, Endres K, Fahrenholz F (2009) Upregulation of the β-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J 23:1643–1654. CrossRef Medline
42. Tong M, Arora K, White MM, Nichols RA (2011) Role of key aromatic residues in the ligand-binding domain of β7 nicotinic receptors in the agonist action of β-amyloid. J Biol Chem 286:34373–34381. CrossRef Medline
43. Wang HY, Lee DH, D’Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) β-amyloid1–42 binds to β7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer’s disease. J Biol Chem 275:5626-5632. CrossRef Medline
44. Wang Q, Klyubin I, Wright S, Griswold-Prenner I, Rowan MJ, Anwyl R (2008) βv integrins mediate beta-amyloid induced inhibition of longterm potentiation. Neurobiol Aging 29:1485–1493. CrossRef Medline
45. Whitson JS, Selkoe DJ, Cotman CW (1989) Amyloidβ protein enhances the survival of hippocampal neurons in vitro. Science 243:1488-1490. CrossRef Medline